NICE approves eye drug for diabetes sufferers


Thousands of people with a devastating eye condition could be offered a potentially sight-saving treatment following a U-turn by the health watchdog.

In 2011 the National Institute of Health and Clinical Excellence refused to make Lucentis available on the NHS because it was too expensive.

But NICE has now reversed its decision for some sufferers.

Baroness Young, Chief Executive of Diabetes UK, said 25,000 people could now benefit from the treatment being available on the NHS.

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.